Home > Resources > Whitepapers > White Paper on India’s Biotechnology Start-up Ecosystem

White Paper on India’s Biotechnology Start-up Ecosystem

A preliminary study was undertaken by ABLE to understand the density of biotech start-ups (as per the definition prescribed by Start-up India policy). A key finding of the study is that the number of start-ups in the biotechnology space between January 1, 2012 and December 31, 2016 is over 1022. It maybe recalled that industry, policy makers, and the other stakeholders in the country, a few years ago around 2012-13, had identified “startups” as one of the important drivers for biotech’s growth in future. At one of the deliberations between industry and the Department of Biotechnology (DBT), the participating leaders did a quick calculation and suggested a target of creating 2000 biotech start-ups by 2020. This was to promote innovation and R&D. This was accepted as a guidance number. ABLE decided to do a quick study to find out the status of start-ups and check if the industry is on track?

Spotlight

Decibel Therapeutics

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.